Bristol Will Buy Diabetes Drug Maker

Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease.

  • Better Buy: GlaxoSmithKline plc vs. Merck -
    Janumet treatments for diabetes are ... s Keytruda cancer drug have lagged behind a rival treatment, Bristol ... buy right now. The article ...
    07/1/2016 - 9:17 am | View Link
  • Decoding Big Pharma's Secret Drug Pricing Practices - Bloomberg
    Secret Drug Pricing Practices Health insurance companies buy ... Plc, Novartis AG and Bristol-Myers Squibb ... for many classes of diabetes ...
    06/29/2016 - 5:19 am | View Link
  • Berko: Drug metformin could be elixir to aging process -
    ... you’d buy the stock. I’ve had some good luck buying stock in drug ... 1957, is an oral diabetes medicine ... in the U.S. Resultantly, ...
    06/19/2016 - 9:22 am | View Link
  • Anti-Obesity Drugs Market: Segments, Dynamics, Size, Forecast, ... -
    ... such as antidepressant, diabetes ... To Buy Report: http://www ... However, the drug is acting by very ... market are Arena ...
    06/16/2016 - 3:33 pm | View Link
  • Better Buy: Johnson & Johnson vs. Eli Lilly - Motley Fool
    ... in the growing diabetes space. ... metrics to see which is the better buy. ... of rights to U.S. sales from  Bristol-Myers Squibb . The ...
    06/15/2016 - 12:26 pm | View Link
  • More
  • AstraZeneca to Buy Bristol’s Stake in Diabetes Joint Venture
    AstraZeneca (AZN) agreed on Thursday to buy Bristol-Myers Squibb’s ... an advisory panel recommended that the U.S. Food and Drug Administration approve dapagliflozin, an experimental treatment for Type 2 diabetes. A similar treatment from Johnson ...
    12/19/2013 - 8:03 pm | View Link
  • Astra to Buy Stake in Diabetes Venture From Bristol for Up to $4.1 Billion
    Earlier this year, Bristol and AstraZeneca deepened their partnership by merging their diabetes-drug marketing teams. But sales at the diabetes venture, which was established in 2007 to develop the therapy Onglyza, have disappointed analysts. AstraZeneca ...
    12/19/2013 - 3:10 am | View Link
  • AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 billion
    The move will bulk up AstraZeneca's thin drug portfolio and give Bristol ... Speculation that AstraZeneca might look to buy out Bristol was fuelled last month when the U.S.-based company decided to get out of diabetes research. The decision to quit ...
    12/18/2013 - 8:39 pm | View Link
  • Bristol-Myers to buy diabetes drug maker for $5 billion
    Bristol-Myers Squibb Co. said it plans to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash. Bristol-Myers will enter an agreement with British drug maker AstraZeneca to develop and commercialize Amylin's diabetes drugs, the ...
    07/1/2012 - 7:04 pm | View Link
  • Bristol-Myers Squibb Co. agrees to buy diabetes drugmaker
    NEW YORK — Bristol-Myers Squibb Co. agreed to buy diabetes drugmaker Amylin Pharmaceuticals for about $5 billion in cash, heating up the competition among drug producers to develop diabetes treatments. After the deal is complete, Bristol-Myers will enter ...
    07/1/2012 - 10:26 am | View Link
  • More
  • PharmaPoint: Type 2 Diabetes
    PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update
    06/28/2016 - 12:20 pm | View Website
  • Bristol-Myers Squibb | FiercePharma
    BMS CEO Lamberto Andreotti 15. Bristol-Myers Squibb ($BMY) 2014 revenue: $15.879 billion 2013 revenue: $16.385 billion Over the past several years, as its Big Pharma ...
    06/28/2016 - 1:36 am | View Website
  • Cafepharma | Home
    News and information for pharmaceutical reps.
    06/28/2016 - 12:10 am | View Website
  • Drug Companies Are Big Business
    Discusses the pharmaceutical companies and their successful multibillion dollar business at our expense. Also, explains the connection between the drug companies and ...
    06/26/2016 - 12:58 pm | View Website
  • Generic Drugs
    Glucophage, for example, is Bristol-Myers Squibb’s brand of the drug whose generic name is metformin. For years, Glucophage was the only brand of metformin on the U ...
    06/26/2016 - 12:51 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News